Relay Therapeutics and Elevar Forge Worldwide License for Lirafugratinib
Relay Therapeutics Inc, a precision medicine company specializing in drug discovery through advanced computational and experimental methods, and Elevar Therapeutics Inc, a division under HLB Co Ltd and a comprehensive biopharmaceutical entity committed to enhancing treatment success for patients without […]
Relay Therapeutics and Elevar Forge Worldwide License for Lirafugratinib Read More »